Discharge Instructions for Venous Thromboembolism (VTE): A Comprehensive Approach to Medication Management | Joint Commission
Follow us on Twitter Friend us on Facebook Vimeo linkedIn Share with your Friends Print this Page
 
Monday 7:22 CST, June 26, 2017

Topic Details

signupsmallfinal

Topic Library Item

Discharge Instructions for Venous Thromboembolism (VTE): A Comprehensive Approach to Medication Management

June 12, 2017

Discharge Instructions / Education Materials for Venous Thromboembolism (VTE):  A Comprehensive Approach to Medication Management

Available now!
The Joint Commission recently developed a Compendium of Resources designed to provide clinicians and other health care educators with reliable and up-to-date patient education and discharge materials for venous thromboembolism (VTE) patients discharged on anticoagulants.  This resource document contains descriptions of resources and websites that provide patient education materials related to the use of anticoagulants for VTE. Health care organizations are encouraged to review and consult this compendium as they adapt their own patient discharge instructions and / or education materials for VTE and anticoagulation therapy.

This Compendium of Resources was developed as part of an 18-month research project, funded by Bristol Myers-Squibb / Pfizer, Inc., aimed at determining what, if any, patient education materials were being provided for patients discharged on anticoagulants other than warfarin (click here for the project executive summary). 

Discharge instructions for VTE have typically included medication management recommendations related to the use of warfarin.  In recent years, however, a growing number of alternatives to warfarin, such as direct oral anticoagulants (DOACs) and other anticoagulants are being more widely used.  These medications eliminate many of the complex monitoring challenges associated with warfarin, but are not without safety concerns.  Since January 1, 2017, Joint Commission surveyors have identified multiple compliance issues, across hospital, nursing care and ambulatory health care settings, associated with the provision of appropriate patient education around the use of anticoagulant medications (NPSG.03.05.01, EP 7).  It is important that all patients discharged on anticoagulants receive clear, comprehensive, and up-to-date education and discharge instructions so they can manage their treatment in a way that is both safe and effective.

Please direct questions or comments about this project to: VTEDischargeInstructions@jointcommission.org


Related links:

The Joint Commission’s VTE performance measures

Joint Commission Center for Transforming Healthcare’s VTE prevention project

 
shareslide1